سوق خدمات سلامة القلب في أمريكا الشمالية – اتجاهات الصناعة والتوقعات حتى عام 2029

تحليل السوق والرؤى

إن سوق خدمات سلامة القلب في أمريكا الشمالية مدفوع بعوامل مثل زيادة عدد التجارب السريرية، وعدد متزايد من اللاعبين الرئيسيين في السوق والابتكار في التكنولوجيا، مما يعزز الطلب عليها، فضلاً عن زيادة الاستثمار في البحث والتطوير، مما يؤدي إلى نمو السوق. حاليًا، تجري دراسات بحثية مختلفة، ومن المتوقع أن تخلق ميزة تنافسية للشركات المصنعة لتطوير أنظمة خدمات سلامة القلب الجديدة والمبتكرة، ومن المتوقع أن توفر العديد من الفرص الأخرى في سوق خدمات سلامة القلب. ومع ذلك، من المتوقع أن تعيق اللوائح الحكومية الصارمة بشأن الموافقة النمو.

يقدم تقرير سوق خدمات سلامة القلب في أمريكا الشمالية تفاصيل عن حصة السوق والتطورات الجديدة وتحليل خط أنابيب المنتجات وتأثير اللاعبين المحليين والمحليين في السوق وتحليل الفرص من حيث جيوب الإيرادات الناشئة والتغييرات في لوائح السوق وموافقات المنتجات والقرارات الاستراتيجية وإطلاق المنتجات والتوسعات الجغرافية والابتكارات التكنولوجية في السوق. لفهم التحليل وسيناريو السوق، اتصل بنا للحصول على موجز محلل، وسيساعدك فريقنا في إنشاء حل لتأثير الإيرادات لتحقيق هدفك المنشود. إن قابلية التوسع وتوسع أعمال وحدات البيع بالتجزئة في البلدان النامية في مختلف المناطق والشراكة مع الموردين للتوزيع الآمن لمنتجات الآلات والأدوية هي المحركات الرئيسية التي دفعت الطلب في السوق في فترة التنبؤ.

يعتبر سوق خدمات سلامة القلب في أمريكا الشمالية داعمًا ويهدف إلى الحد من تطور المرض. تحلل شركة Data Bridge Market Research أن سوق خدمات سلامة القلب في أمريكا الشمالية سينمو بمعدل نمو سنوي مركب بنسبة 15.7٪ خلال الفترة المتوقعة من 2022 إلى 2029.

Market Definition:

Cardiac safety services generally help support and design clinical trials and other research needed to monitor heart safety. The demand for cardiac safety services market has been increased in both developed well as in developing countries and the reason behind this is the increasing number of clinical trials and product launch. The cardiac safety services market is growing due to introduction of innovative products, increasing in technological products and rising disposable income. The market will grow in forecasted period due to exploration of emerging markets, strategic initiatives by market players, increasing healthcare expenditure.

North America Cardiac safety services Market Dynamics

Drivers

• Increase in the number of clinical trials

A clinical trial is a well-structured system that is way back hundreds of years and is still the backbone of the regulatory requirements required for a drug to be approved. Recently there has been much advancement in the clinical trial field, which has increased the number of clinical trials and is expected to propel the market growth.

There have been various changes in the regulatory of the clinical trials, which has increased the number of clinical trials and their positive results-

For instance,

• According to the article by Medical News, there has been a significant increase in the number of trials due to the rise in the quality of clinical trials, such as mandatory training of all staff. Also, in 2017, NIH stated that all investigators and staff should be trained on good clinical practice (GCP) in trials that NIH funds

Increase in healthcare expenditure and funding

The expanse of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization of the health system.

Healthcare expenditure has increased across developed countries and emerging economies as the disposable income of people are growing. The more money is spent on healthcare, the healthier a country's population is.

Opportunity

•  Increase in new drug development

The clinical trials are vital for discovering and developing new drugs for disease treatment. It is the best way researchers can find out what treatments work or don't work on humans. The drug development is characterized as forming new treatment as medicines or devices for curing various diseases such as cancer, endocrine, metabolic, and others.

• Thus, clinical trials are the most effective way to ensure the safety and efficacy of the therapeutic drug before launching in the market and human consumption that includes cardiac safety evaluation which is an essential part before any medical product goes into the market

Restraint/Challenge

The proper assessment and reporting of clinical cardiac safety data is essential. Approval and product recall for any medical products depend on cardiac safety evaluation. So it is necessary to provide and conduct cardiac safety evaluation according to the legal procedure, otherwise it leads to late approval of the product which is expected to restrain the market growth.

For instance,

• According to the article by IQVIA, there were 47 instances of post-marketing withdrawal of drugs between 1957 and 2007, in which 45% of these were due to concerns regarding cardiovascular toxicity. Similarly, 27% of the potential new drug molecules that failed in the preclinical phase in the last two decades did so because of cardiovascular toxicity as they did not meet the required regulatory

North America Cardiac Safety Services Market Segmentation

North America cardiac safety services market is categorized into type, services, phase and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Services

• ECG/holter measurements
• Blood pressure measurements
• In vitro cardiac safety assessment services
• Cardiovascular imaging
• Real-time telemetry monitoring
• Central over-read of ECGS
• Non-invasive cardiac imaging
• Physiologic stress testing
• Thorough QT studies
• TQT and exposure response modeling
• Platelet aggregation
• Other services

On the basis of services, the cardiac safety services market is segmented into ECG/Holter measurements, blood pressure measurements, in vitro cardiac safety assessment services, cardiovascular imaging, real-time telemetry monitoring, central over-read of ECGS, non-invasive cardiac imaging, physiologic stress testing, thorough QT studies, TQT and exposure response modeling, platelet aggregation and other services

Phase

• Phase 1
• Phase 2
• Phase 3

On the basis of phases, the cardiac safety services market is segmented into phase 1, phase 2, and phase 3.

Type

• Integrated services
• Standalone services

On the basis of type, the cardiac safety services market is segmented into integrated services and standalone services.

End User

• Pharmaceuticals & Biopharmaceuticals Companies
• Contract Research Organizations
• Academic and Research Institute

On the basis of end user, the cardiac safety services market is segmented pharmaceuticals & biopharmaceuticals companies, contract research organizations, and academic and research institute.

Cardiac Safety Services Regional Analysis/Insights

The cardiac safety services is analysed and market size insights and trends are provided by type, services, phase and end user as referenced above.

The countries covered in the cardiac safety services report are U.S., Canada and Mexico.

The U.S. is expected to dominate due to increase in technological advancement in the developing areas.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Cardiac Safety Services Analysis

North America Cardiac safety services Market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on cardiac safety services market.

Some of the major players in the market are Koninklijke Philips N.V., Laboratory Corporation of America Holdings, IQVIA, Medpace, Ncardia, Certara, Eurofins Scientific, SGS SA, Banook, Celerion, Biotrial, NEXEL Co., Ltd, Richmond Pharmacology, PhysioStim, Shanghai Medicilon Inc, Clario, PPD Inc among others.

Research Methodology

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. بالإضافة إلى ذلك، يعد تحليل حصة السوق وتحليل الاتجاهات الرئيسية من عوامل النجاح الرئيسية في تقرير السوق. منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي مثلث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأساسي (خبير الصناعة). وبصرف النظر عن هذا، تتضمن نماذج البيانات شبكة وضع البائعين وتحليل الخط الزمني للسوق ونظرة عامة على السوق والدليل وشبكة وضع الشركة وتحليل حصة الشركة في السوق ومعايير القياس وتحليل أمريكا الشمالية مقابل المنطقة وحصة البائعين. يرجى طلب مكالمة محلل في حالة وجود استفسار آخر.

SKU-68237